Answer
Tafasitamab can cause serious and/or severe myelosuppression, including neutropenia, thrombocytopenia and anaemia.
Sources for this answer
- MINJUVI 200 mg powder for concentrate for solution for infusionIncyte Biosciences UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked